References
Matar MJ, Tarrand J, Raad I, Rolston KV (2006) Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 34(8):534–536
Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E et al (2007) Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 13(5):615–621
Linden PK (2007) Optimizing therapy for vancomycin-resistant enterococci (VRE). Semin Respir Crit Care Med 28(6):632–645
Kelesidis T, Humphries R, Uslan DZ, Pegues DA (2011) Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin Infect Dis 52(2):228–234
Sader HS, Jones RN (2009) Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007–2008). Diagn Microbiol Infect Dis 65(2):158–162
Kamboj M, Cohen N, Gilhuley K, Babady NE, Seo SK, Sepkowitz KA (2011) Emergence of daptomycin-resistant VRE: experience of a single institution. Infect Control Hosp Epidemiol 32(4):391–394
Silverman JA, Oliver N, Andrew T, Li T (2001) Resistance studies with daptomycin. Antimicrob Agents Chemother 45(6):1799–1802
Palmer KL, Daniel A, Hardy C, Silverman J, Gilmore MS (2011) Genetic basis for daptomycin resistance in enterococci. Antimicrob Agents Chemother 55(7):3345–3356
Kelesidis T, Humphries R, Uslan DZ, Pegues D (2012) De novo daptomycin-nonsusceptible enterococcal infections. Emerg Infect Dis 18(4):674–676
King ST, Usery JB, Holloway K, Koeth L, Cleveland KO, Gelfand MS (2011) Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections. J Antimicrob Chemother 66(11):2673–2675
Financial disclosure statement
The authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wudhikarn, K., Gingrich, R.D. & de Magalhaes Silverman, M. Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat. Ann Hematol 92, 129–131 (2013). https://doi.org/10.1007/s00277-012-1539-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-012-1539-6